Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma

被引：0
|
作者：
Pabon, Cindy M.
Xiao, Lianchun
Badgwell, Brian D.
Mansfield, Paul F.
Ikoma, Naruhiko
Sewastjanow-Silva, Matheus
Lee, Jeffrey H.
Bhutani, Manoop S.
Weston, Brian
Coronel, Emmanuel
Smith, Grace L.
Holliday, Emma
Tian, Jessie
Das, Prajnan
Minsky, Bruce D.
Waters, Rebecca E.
Estrella, Jeannelyn
Li, Jenny Jing
Ajani, Jaffer A.
Murphy, Mariela A. Blum
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Radiat Oncol, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Gastrointestinal Med Oncol, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4067
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
    Rodabe N. Amaria
    Sangeetha M. Reddy
    Hussein A. Tawbi
    Michael A. Davies
    Merrick I. Ross
    Isabella C. Glitza
    Janice N. Cormier
    Carol Lewis
    Wen-Jen Hwu
    Ehab Hanna
    Adi Diab
    Michael K. Wong
    Richard Royal
    Neil Gross
    Randal Weber
    Stephen Y. Lai
    Richard Ehlers
    Jorge Blando
    Denái R. Milton
    Scott Woodman
    Robin Kageyama
    Daniel K. Wells
    Patrick Hwu
    Sapna P. Patel
    Anthony Lucci
    Amy Hessel
    Jeffrey E. Lee
    Jeffrey Gershenwald
    Lauren Simpson
    Elizabeth M. Burton
    Liberty Posada
    Lauren Haydu
    Linghua Wang
    Shaojun Zhang
    Alexander J. Lazar
    Courtney W. Hudgens
    Vancheswaran Gopalakrishnan
    Alexandre Reuben
    Miles C. Andrews
    Christine N. Spencer
    Victor Prieto
    Padmanee Sharma
    James Allison
    Michael T. Tetzlaff
    Jennifer A. Wargo
    Nature Medicine, 2018, 24 : 1649 - 1654
  • [32] Efficacy and toxicity of neoadjuvant immune checkpoint inhibitors in resectable gastric cancer: A meta-analysis and systematic review
    Li, Song
    Xu, Qian
    Dai, Xin
    Zhang, Xue
    Huang, Miao
    Huang, Kai
    Wang, Jian
    Chu, Jiahui
    Liu, Lian
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [33] Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
    Amaria, Rodabe N.
    Reddy, Sangeetha M.
    Tawbi, Hussein A.
    Davies, Michael A.
    Ross, Merrick, I
    Glitza, Isabella C.
    Cormier, Janice N.
    Lewis, Carol
    Hwu, Wen-Jen
    Hanna, Ehab
    Diab, Adi
    Wong, Michael K.
    Royal, Richard
    Gross, Neil
    Weber, Randal
    Lai, Stephen Y.
    Ehlers, Richard
    Blando, Jorge
    Milton, Denai R.
    Woodman, Scott
    Kageyama, Robin
    Wells, Daniel K.
    Hwu, Patrick
    Patel, Sapna P.
    Lucci, Anthony
    Hessel, Amy
    Lee, Jeffrey E.
    Gershenwald, Jeffrey
    Simpson, Lauren
    Burton, Elizabeth M.
    Posada, Liberty
    Haydu, Lauren
    Wang, Linghua
    Zhang, Shaojun
    Lazar, Alexanderj
    Hudgens, Courtney W.
    Gopalakrishnan, Vancheswaran
    Reuben, Alexandre
    Andrews, Miles C.
    Spencer, Christine N.
    Prieto, Victor
    Sharma, Padmanee
    Allison, James
    Tetzlaff, Michael T.
    Wargo, Jennifer A.
    NATURE MEDICINE, 2018, 24 (11) : 1649 - +
  • [34] Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma
    Ben Ashman, Jonathan
    Moss, Adyr A.
    Callister, Matthew D.
    Reddy, Kunam S.
    Mulligan, David C.
    Gunderson, Leonard L.
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [35] Dose Escalation With a Vessel Boost in Borderline Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Chemoradiation
    Wang, L.
    Handorf, E.
    Shaikh, T.
    Hoffman, J. P.
    Cohen, S. J.
    Meyer, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S359 - S359
  • [36] Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
    Lin, Feizhi
    Chen, Yongming
    Huang, Bowen
    Ruan, Shenghang
    Lin, Jun
    Chen, Zewei
    Huang, Chunyu
    Zhao, Baiwei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [37] Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
    Tian, Yuan
    Zhao, Qun
    Li, Yong
    Fan, Liqiao
    Zhang, Zhidong
    Zhao, Xuefeng
    Tan, Bibo
    Wang, Dong
    Yang, Peigang
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [38] Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
    Rizzo, Alessandro
    THORACIC CANCER, 2022, 13 (21) : 3098 - 3098
  • [39] Margin Status and Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer
    Papavasiliou, P.
    Piposar, J. R.
    Arrangoiz, R.
    Chen, K. T.
    Zhu, F.
    Chun, Y.
    Hoffman, P.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S157 - S157
  • [40] Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma
    Fan, Kelly
    Waninger, Jessica J.
    Yentz, Sarah
    McLean, Scott
    Demirci, Hakan
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (05): : E152 - E155
12345